141 related articles for article (PubMed ID: 35983381)
1. Coverage of Coronavirus Disease-2019 (COVID-19) Booster Dose (Precautionary) in the Adult Population: An Online Survey.
Masthi Nr R; Brahmajosyula A; Khamar A; Acharya N; Bilichod LP; Kondath D
Cureus; 2022 Jul; 14(7):e26912. PubMed ID: 35983381
[TBL] [Abstract][Full Text] [Related]
2. Safety monitoring of precautionary third dose of COVID-19 vaccines in a district in Northern India.
Deb T; Misra S; Kaur M; Verma N; Kairi JK; Sindhu N
J Family Med Prim Care; 2024 May; 13(5):1875-1880. PubMed ID: 38948581
[TBL] [Abstract][Full Text] [Related]
3. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey.
Krishna E; Karthikeyan V; Ahmad S; Ranjan A; Hasan Km A; Pandey S; Kumar P; Singh CM
Cureus; 2023 Nov; 15(11):e49363. PubMed ID: 38146559
[TBL] [Abstract][Full Text] [Related]
4. Boosters and time from the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment.
Russo AG; Murtas R; Tunesi S; Decarli A; Bergamaschi W
Epidemiol Prev; 2022; 46(1-2):34-46. PubMed ID: 35354266
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland.
Babicki M; Mastalerz-Migas A
Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062729
[TBL] [Abstract][Full Text] [Related]
6. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
Rababa'h AM; Abedalqader NN; Ababneh M
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study.
Lounis M; Bencherit D; Rais MA; Riad A
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455371
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, acceptance, motivators and barriers of booster dose of COVID-19 vaccination among dental patients: A cross-sectional study.
Faraz A; Hina M; Atif A; Sumbul D; Mahmood SE; Riaz F; Khan MS; Ahmad A; Ahmad MT; Parvez A; Zeyaullah M
Medicine (Baltimore); 2023 Nov; 102(45):e35747. PubMed ID: 37960831
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
10. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
Front Public Health; 2022; 10():914950. PubMed ID: 35903387
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
[TBL] [Abstract][Full Text] [Related]
12. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.
Qin C; Wang R; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():834572. PubMed ID: 35372197
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants.
Abouzid M; Ahmed AA; El-Sherif DM; Alonazi WB; Eatmann AI; Alshehri MM; Saleh RN; Ahmed MH; Aziz IA; Abdelslam AE; Omran AA; Omar AA; Ghorab MA; Islam SMS
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016158
[TBL] [Abstract][Full Text] [Related]
14. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India.
Sharma N; Basu S; Lalwani H; Rao S; Malik M; Garg S; Shrivastava R; Singh MM
Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514993
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
17. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review.
Chenchula S; Karunakaran P; Sharma S; Chavan M
J Med Virol; 2022 Jul; 94(7):2969-2976. PubMed ID: 35246846
[TBL] [Abstract][Full Text] [Related]
18. Perception and practices on COVID-19 vaccination and booster dose acceptability among health-care workers - A questionnaire-based study.
Rathinakumar NK; Nishanthi A; Manickam S
Perspect Clin Res; 2024; 15(1):10-17. PubMed ID: 38282629
[TBL] [Abstract][Full Text] [Related]
19. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland.
Rzymski P; Poniedziałek B; Fal A
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835217
[TBL] [Abstract][Full Text] [Related]
20. Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China.
Lin XQ; Li AL; Zhang MX; Lv L; Chen Y; Chen HD; Tung TH; Zhu JS
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
